Individual differences in human opioid abuse potential as observed in a human laboratory study

被引:11
作者
Dunn, Kelly E. [1 ]
Barrett, Frederick S. [1 ]
Brands, Bruna [2 ,3 ,4 ]
Marsh, David C. [5 ]
Bigelow, George E. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Behav Pharmacol Res Unit, 5510 Nathan Shock Dr, Baltimore, MD 21218 USA
[2] Hlth Canada, Ottawa, ON, Canada
[3] Ctr Addict & Mental Hlth, Toronto, ON, Canada
[4] Univ Toronto, Toronto, ON, Canada
[5] Northern Ontario Sch Med, Sudbury, ON, Canada
关键词
Opioid; Human individual differences; Heroin; Hydromorphone; Personalized medicine; PHYSICAL-DEPENDENCE; NALOXONE; HYDROMORPHONE; OPIATE; PREDICTORS; NALTREXONE; LIABILITY; EVALUATE; COCAINE; HEROIN;
D O I
10.1016/j.drugalcdep.2019.107688
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Opioids have high abuse potential and pose a major public health concern. Yet, a large percentage of individuals exposed to opioids do not develop problematic use. Individual differences in opioid abuse potential are not well understood. Methods: This within-subject (N = 16), double-blind, double-dummy, human laboratory study evaluated individual differences in response to dose (placebo, low, medium, high) following administration of heroin and hydromorphone through intravenous and subcutaneous routes, in opioid-experienced but non physically-dependent participants. Outcomes were self-reported visual analog scale (VAS) ratings (High, Liking, Drug Effect, Good Effect, Rush), pupil diameter change from baseline, and crossover point on the Drug vs. Money questionnaire. The degree to which results were consistent across measures within an individual was assessed using a mixed-effects model from which an intraclass correlation coefficient measure of between and within-subject variance was derived. Results: The mixed effects model fit was significant (p < 0.0001) and revealed that 85.5% of the explainable variance was due to between-subject effects, suggesting the responses within an individual were highly consistent. Visual inspection reveals a myriad response pattern across participants, with some demonstrating classic dose-effect responses and others not differentiating any active doses from placebo. Conclusions: Data suggest the abuse potential of opioids is significantly different between individuals but that the experience within an individual is highly consistent. Research to prospectively characterize and evaluate mechanisms underlying these differences is warranted and may provide a foundation to help identify persons at heightened risk of transitioning from opioid exposure to misuse and/or opioid use disorder.
引用
收藏
页数:5
相关论文
共 35 条
  • [1] NEW LOOK AT STATISTICAL-MODEL IDENTIFICATION
    AKAIKE, H
    [J]. IEEE TRANSACTIONS ON AUTOMATIC CONTROL, 1974, AC19 (06) : 716 - 723
  • [2] [Anonymous], BR J ANAESTH
  • [3] [Anonymous], ASS POT DRUGS GUID I
  • [4] [Anonymous], 2001, HIERARCHICAL LINEAR
  • [5] Opioid abusers' ability to differentiate an opioid from placebo in laboratory challenge testing
    Antoine, Denis G.
    Strain, Eric C.
    Tompkins, D. Andrew
    Bigelow, George E.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2013, 132 (1-2) : 369 - 372
  • [6] Fast and Elegant Numerical Linear Algebra Using the RcppEigen Package
    Bates, Douglas
    Eddelbuettel, Dirk
    [J]. JOURNAL OF STATISTICAL SOFTWARE, 2013, 52 (05): : 1 - 24
  • [7] BICKEL WK, 1988, J PHARMACOL EXP THER, V244, P126
  • [8] BICKEL WK, 1989, J PHARMACOL EXP THER, V251, P1053
  • [9] Opioid genetics: the key to personalized pain control?
    Branford, R.
    Droney, J.
    Ross, J. R.
    [J]. CLINICAL GENETICS, 2012, 82 (04) : 301 - 310
  • [10] Observational study to calculate addictive risk to opioids: a validation study of a predictive algorithm to evaluate opioid use disorder
    Brenton, Ashley
    Richeimer, Steven
    Sharma, Maneesh
    Lee, Chee
    Kantorovich, Svetlana
    Blanchard, John
    Meshkin, Brian
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2017, 10 : 187 - 195